Med Spa Valuation Multiples in 2026: What the Market Is Paying

The med spa M&A market has matured significantly over the past three years. Private equity groups that were exploring the space in 2022–2023 are now active acquirers with established playbooks. This maturation has brought more discipline to valuations — both in terms of what buyers will pay and what they will not.

Our team has direct relationships with PE groups actively acquiring in this space and has been involved in transactions on both sides. Here is what the market looks like in 2026.

Med spa valuations are primarily driven by two metrics:

EBITDA multiple: The most common valuation framework. Adjusted EBITDA (normalized for owner compensation, one-time items, and non-recurring revenue) is multiplied by a market multiple.

Per-patient valuation: A secondary metric that is particularly useful for practices with strong patient bases but variable EBITDA. We have seen PE groups paying approximately $2,500 per active patient for well-run practices.

The range of EBITDA multiples in the current market:

These are general ranges. Specific multiples depend on the factors discussed below.

The single biggest driver of premium multiples is recurring revenue. Practices with:

• Monthly GLP-1 membership programs
• Subscription-based wellness programs
• Loyalty programs with high retention

...command significantly higher multiples than practices with purely transactional revenue.

A practice with 60% recurring revenue will typically command a 1–2x higher multiple than an identical practice with 20% recurring revenue.

GLP-1 weight management programs have become a major value driver in med spa acquisitions. PE buyers are specifically seeking practices with:

• Established GLP-1 patient bases
• Documented patient retention metrics
• Compliant supply chain relationships
• Telehealth capability for GLP-1 prescribing

Practices with significant GLP-1 revenue are commanding premium multiples in the current market.

Telehealth capability dramatically increases the scalability of a practice. PE buyers can grow a telehealth-enabled practice without proportional increases in physical infrastructure. This scalability commands a premium.

Multi-location practices command higher multiples because:

• They demonstrate the business model is replicable
• They reduce key-person risk
• They provide a platform for further acquisition

A single significant compliance issue can reduce a multiple by 1–2x or kill a deal entirely. Clean compliance records are increasingly important as PE buyers have become more sophisticated about healthcare regulatory risk.

Practices where the value is not entirely dependent on the founder command higher multiples. PE buyers want to know the business can run without the seller.

If more than 30–40% of revenue comes from a single service line, single provider, or single payer, buyers will discount the multiple to account for concentration risk.

A lease with less than 2–3 years remaining (without renewal options) creates uncertainty that buyers discount.

Any history of board actions, regulatory violations, or litigation will suppress multiples or kill deals.

If the practice's patient relationships are entirely with the founder, buyers will be concerned about patient retention post-acquisition.

Revenue that is declining or flat will suppress multiples. Buyers want growth.

GLP-1 programs have become a specific value driver in the current market. Practices with established, compliant GLP-1 programs are commanding a premium over practices without them.

The reasons:

• GLP-1 programs generate recurring monthly revenue
• The patient population is growing rapidly
• Telehealth-enabled GLP-1 prescribing is highly scalable
• PE buyers see GLP-1 as a long-term growth driver

For practices that do not yet have a GLP-1 program, adding one before a sale can meaningfully increase the exit multiple.

1. Build recurring revenue: Convert transactional patients to membership or subscription models
2. Add a GLP-1 program: If you do not have one, add it before going to market
3. Enable telehealth: Telehealth capability increases scalability and multiple
4. Clean up compliance: Address any outstanding compliance issues before going to market
5. Document your patient base: Ensure patient records are complete and retention metrics are documented
6. Reduce founder dependency: Build a management team and document protocols

Start the M&A conversation →

This content is for informational purposes only and does not constitute legal or financial advice. Valuations vary significantly based on individual practice characteristics.